Study targets patients with advanced disease who have progressed on prior immunotherapy CatalYmtoday announced that the first patient has been dosed in the randomized Phase 2b GDFATHER-NSCLC-02 ...

Vestibular Migraine (VM) is a common clinical neurological disorder characterized by recurrent episodes of dizziness and headaches. It has a significant genetic predisposition and a high morbidity and ...

Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Blood Cancer United®—formerly The Leukemia & Lymphoma Society—will celebrate new data presented by Blood Cancer United funded ...

Spinal Cord Injury (SCI) is a devastating neurological disorder that often leads to permanent neural dysfunction. Current ...

Monte Rosa Therapeutics is transitioning from an oncology focus to a next-gen immunology & inflammation platform. Read why ...

Nasal nanodrops carrying gold-based spherical nucleic acids can slip into the brain and activate powerful immune pathways ...

With me today is our Chief Financial Officer, Anthony Pagano; our Chief Commercial Officer, Brad Bailey; and our Chief ...

The IL-6 receptor antagonist market presents significant opportunities in underexplored areas like thyroid eye disease and atherosclerotic cardiovascular disease (ASCVD). Recent acquisitions and ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...

The gut microbiota is the complex and dynamic community of bacteria, fungi, parasites, and viruses that enter into a ...